Keith A. Goldan, Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), sold 2,082 shares at $20.62 ($43K) on 2026-02-06, disclosed to the SEC on 2026-02-06.
Open-market sale of $43k SNDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SNDX | SELL | 2025-07-18 | $12K | — | Filing → |
| SNDX | SELL | 2025-02-12 | $117K | — | Filing → |
| SNDX | BUY | 2024-06-17 | $25K | — | Filing → |